Cargando…
Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
OBJECTIVES: The coronavirus disease (COVID-19) outbreak has catastrophically threatened public health worldwide and presented great challenges for clinicians. To date, no specific drugs are available against severe acute respiratory syndrome coronavirus 2. Mesenchymal stem cells (MSCs) appear to be...
Autores principales: | Wei, Fengtao, Kong, Dexiao, Li, Tao, Li, Ai, Tan, Yi, Fang, Jinfeng, Zhuang, Xianghua, Lai, Chao, Xu, Weihua, Dong, Hong, Ma, Chengen, Hong, Ke, Cui, Yuqin, Tang, Shengbin, Yu, Fenggang, Zheng, Chengyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Medicina / USP
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101688/ https://www.ncbi.nlm.nih.gov/pubmed/34008772 http://dx.doi.org/10.6061/clinics/2021/e2604 |
Ejemplares similares
-
Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis
por: Li, Ai, et al.
Publicado: (2017) -
Laminin 411 acts as a potent inducer of umbilical cord mesenchymal stem cell differentiation into insulin-producing cells
por: Qu, Huiting, et al.
Publicado: (2014) -
Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19
por: Li, Tao, et al.
Publicado: (2021) -
Effect of Microenvironment on Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Hepatocytes In Vitro and In Vivo
por: Xue, Gai, et al.
Publicado: (2016) -
Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus
por: Lian, Xiao-Fen, et al.
Publicado: (2022)